Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-services domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/benchmarkantibodiescom_769/public/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-payments domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/benchmarkantibodiescom_769/public/wp-includes/functions.php on line 6121
BCA-225 – benchmark antibodies BCA-225
Skip to content
Close

Showing the single result

BCA-225

BCA-225: BCA-225 is a breast cancer marker often used in research and clinical settings. Its detection can provide insights into tumor characteristics and treatment responses.



target type reactivity applications
6027 BCA-225 mouse monoclonal (Cu-18) human IHC

Human breast adenocarcinoma stained with anti-BCA-255 antibody using peroxidase-conjugate and DAB chromogen. Note the cytoplasmic staining of tumor cells.
IHC with antibody [6027] : Human breast adenocarcinoma stained with anti-BCA-255 antibody using peroxidase-conjugate and DAB chromogen. Note the cytoplasmic staining of tumor cells.
ICC
IHC